For all the concern seen in the health and research communities Thursday following the release of the White House’s preliminary budget recommendations, there was one clear winner, or at least non-loser: Gavi, the global vaccine alliance.
Despite deep proposed cuts to the Department of Health and Human Services and the National Institutes of Health, the budget blueprint released by the Trump administration preserves a billion-dollar commitment to Gavi over four years. The United States had previously committed that amount to the cause between 2015 and 2018, and it accounts for a major component of Gavi’s income.
Gavi offers heavily subsidized vaccines to poor countries, funds studies about vaccine use and development, and provides logistical support in countries where vaccine storage capacity has been threatened.
About the Author Reprints
